MedPath

Fondazione Epatocentro Ticino

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease

Recruiting
Conditions
NAFLD
MASH
NASH/MASH
First Posted Date
2025-07-04
Last Posted Date
2025-07-09
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
200
Registration Number
NCT07051863
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

Methylene Blue Treatment of COVID-19

Phase 2
Conditions
SARS-CoV2
Interventions
Drug: Control Test
First Posted Date
2020-11-19
Last Posted Date
2022-04-20
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
64
Registration Number
NCT04635605
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

Swiss Autoimmune Hepatitis Cohort Study

Conditions
Hepatitis, Autoimmune
First Posted Date
2017-05-10
Last Posted Date
2022-04-20
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
500
Registration Number
NCT03146884
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

🇨🇭

Gastroenterologie und Hepatologie Clarunis - Universitäres Bauchzentrum, Universitätsspital Basel, Basel, Switzerland

🇨🇭

Universitäts-Kinderspital beider Basel UKBB, Gastroenterologie&Ernährung, Basel, Switzerland

and more 15 locations

Swiss Primary Sclerosing Cholangitis Cohort Study

Conditions
Cholangitis, Sclerosing
First Posted Date
2017-05-10
Last Posted Date
2022-04-20
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
120
Registration Number
NCT03146936
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

🇨🇭

Gastroenterologie und Hepatologie Clarunis - Universitäres Bauchzentrum Universitätsspital Basel, Basel, Switzerland

🇨🇭

Universitäts-Kinderspital beider Basel UKBB, Gastroenterologie&Ernährung, Basel, Switzerland

and more 15 locations

Swiss Primary Biliary Cholangitis Cohort Study

Conditions
Liver Cirrhosis, Biliary
First Posted Date
2017-05-10
Last Posted Date
2022-04-20
Lead Sponsor
Fondazione Epatocentro Ticino
Target Recruit Count
500
Registration Number
NCT03146910
Locations
🇨🇭

Fondazione Epatocentro Ticino, Lugano, Ticino, Switzerland

🇨🇭

Gastroenterologie und Hepatologie, Clarunis - Universitäres Bauchzentrum Basel, Basel, Switzerland

🇨🇭

Inselspital, Bern, Switzerland

and more 6 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.